Implantable mechanical circulatory support: Demystifying patients with ventricular assist devices and artificial hearts

Clinical Cardiology

Volumn 34, Issue 3, 2011, Pages 147-152

  Shah, Keyur B ^a   Tang, Daniel G ^b   Cooke, Richard H ^a   Harton, Suzanne ^a   Flattery, Maureen ^a   Katlaps, Gundars J ^b   Kasirajan, Vigneshwar ^b   Hess, Michael L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b McGuire Veteran's Administration Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; DIPYRIDAMOLE;

ABLATION THERAPY; AORTA VALVE DISEASE; AORTA VALVE REGURGITATION; ARTIFICIAL HEART; ASSISTED CIRCULATION; BLEEDING; BRAIN HEMORRHAGE; CONGESTIVE HEART FAILURE; DEVICE INFECTION; DEVICE THERAPY; EPISTAXIS; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART PACING; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MORBIDITY; OBSTRUCTION; PULSATILE FLOW; REVIEW; SEPSIS; SURVIVAL; THROMBOSIS;

EQUIPMENT DESIGN; HEART FAILURE; HEART, ARTIFICIAL; HEART-ASSIST DEVICES; HUMANS;

EID: 79952719506     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20825     Document Type: Review

References (28)

1. Taylor DO, Stehlik J, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-sixth Official Adult Heart Transplant Report - 2009. J Heart Lung Transplant. 2009;28:1007-1022.
2. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a mechanical left ventricular assist device for end-stage heart failure. N Engl JMed. 2001;345:1435-1443.
3. Dembitsky WP, Tector AJ, Park S, et al. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial. Ann Thorac Surg. 2004;78:2123-2130. (Pubitemid 39556308)
4. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-896. (Pubitemid 47347322)
5. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312-321.
6. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-2251.
7. Khalil HA, Cohn WE, Metcalfe RW, et al. Preload sensitivity of the Jarvik 2000 and HeartMate II left ventricular assist devices. ASAIO J. 2008;54:245-248.
8. Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29(4 suppl): S1-S39.
9. Horton SC, Khodaverdian R, Chatelain P, et al. Left ventricular assist device malfunction: an approach to diagnosis by echocardiography. J Am Coll Cardiol. 2005;45:1435-1440. (Pubitemid 40615615)
10. Park MH, Goudreau E, Tolman DE, et al. Fluoroscopy and selective angiography of left ventricular assist system inflow cannula as a method of detecting cannula entrapment. Cathet Cardiovasc Diagn. 1998;44:47-51. (Pubitemid 28201787)
11. Raman SV, Sahu A, Merchant AZ, et al. Noninvasive assessment of left ventricular assist devices with cardiovascular computed tomography and impact on management. J Heart Lung Transplant. 2010;29:79-85.
12. Puwanant S, Hamilton KK, Klodell CT, et al. Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation. J Heart Lung Transplant. 2008;27:1102-1107.
13. Potapov EV, Stepanenko A, Dandel M, et al. Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J Heart Lung Transplant. 2008;27:1275-1281.
14. Ochiai Y, McCarthy PM, Smedira NG, et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation. 2002;106(12 suppl 1): I198-I202.
15. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497-505. (Pubitemid 47450258)
16. Bedi M, Kormos R, Winowich S, et al. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol. 2007;99:1151-1153. (Pubitemid 46562514)
17. Andersen M, Videbaek R, Boesgaard S, et al. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant. 2009;28:733-735.
18. Ziv O, Dizon J, Thosani A, et al. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol. 2005;45:1428-1434. (Pubitemid 40615614)
19. Rose AG, Park SJ, Bank AJ, et al. Partial aortic valve fusion induced by left ventricular assist device. Ann Thorac Surg. 2000;70:1270-1274.
20. Mudd JO, Cuda JD, Halushka M, et al. Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. J Heart Lung Transplant. 2008;27:1269-1274.
21. Spanier T, Oz M, Levin H, et al. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg. 1996;112:1090-1097. (Pubitemid 26339283)
22. Boyle AJ, Russell SD, Teuteberg JJ, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant. 2009;28:881-887.
23. Crow S, John R, Boyle A, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg. 2009;137:208-215.
24. Malehsa D, Meyer AL, Bara C, et al. Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Eur J Cardiothorac Surg. 2009;35:1091-1093.
25. Steinlechner B, Dworschak M, Birkenberg B, et al. Platelet dysfunction in outpatients with left ventricular assist devices. Ann Thorac Surg. 2009;87:131-137.
26. Klovaite J, Gustafsson F, Mortensen SA, et al. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol. 2009;53:2162-2167.
27. Letsou GV, Shah N, Gregoric ID, et al. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant. 2005;24:105-109.
28. Copeland JG, Smith RG, Arabia FA, et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004;351:859-867. (Pubitemid 39099324)